Tag: Teewinot Life Sciences

Canadian investment bank AltaCorp Capital has published a research report explaining options for producing cannabinoids from sources beyond cannabis. Analyst and Managing Director David Kideckel, PhD, explained in “Synthetically-Derived...

Teewinot Life Sciences Corporation’s Subsidiary, Full Spectrum Laboratories, Ltd., Announced Today: Grant of an Important U.S. Patent with Broad Claims to Biosynthetic Production of Cannabinoids Furthers Mission to Address...

CBC Biotechnologies, Inc., a Florida-based biopharmaceutical company focused on the use of synthetic biology to produce cannabinoids, has raised $7mm from investors that include NYC-based Tuatara Capital, which is focused...

- March 8th, 2016 at 4:22 pm

Subscribe

The best cannabis industry news sent to your inbox every Sunday

Cannabis Stocks

The largest and most comprehensive premium subscription service for cannabis traders and investors since 2013.